BioScience Health Innovations (BHIC) Cost of Revenue (2023 - 2025)
BioScience Health Innovations (BHIC) has disclosed Cost of Revenue for 3 consecutive years, with $1.0 million as the latest value for Q4 2025.
- Quarterly Cost of Revenue rose 269.04% to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Dec 2025, up 356.65% year-over-year, with the annual reading at $2.4 million for FY2025, 356.65% up from the prior year.
- Cost of Revenue for Q4 2025 was $1.0 million at BioScience Health Innovations, up from $433196.0 in the prior quarter.
- The five-year high for Cost of Revenue was $1.0 million in Q4 2025, with the low at $4746.0 in Q1 2023.
- Average Cost of Revenue over 3 years is $258105.5, with a median of $111013.5 recorded in 2024.
- Peak annual rise in Cost of Revenue hit 825.53% in 2025, while the deepest fall reached 192.24% in 2025.
- Over 3 years, Cost of Revenue stood at $67117.0 in 2023, then skyrocketed by 304.09% to $271213.0 in 2024, then skyrocketed by 269.04% to $1.0 million in 2025.
- According to Business Quant data, Cost of Revenue over the past three periods came in at $1.0 million, $433196.0, and $682985.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.